Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300258 · ClinicalTrials.gov registry record · NA
Robotic Pedaling Therapy for Targeted Neural Plasticity
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03300258 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 44 participants.
The verdict
NCT03300258, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The aim of this Pilot study is to determine whether robotically targeted lower-limb pedaling therapy can increase the extent of stroke recovery on behavioral measures and induce brain plasticity as measured by functional magnetic resonance imaging (fMRI). Forty (40) adult stroke patients and 80 healthy controls will be enrolled in this study. Of the 40 patients, half will be randomly assigned to the robotically-targeted training ("robotic") group and will receive training on the targeted training task. The other half of the patients will perform a duration-matched aerobic pedaling exercise ("control" group). All stroke patients will be scanned before and after their training program while performing or imagining simple motor tasks. Behavioral assessments of motor and cognitive capacities will be collected at each timepoint. Healthy control subjects enrolled for device testing (20) will receive up to 5 training sessions in a modified robotic paradigm and 1 fMRI scan, in order to investigate motor learning and brain activity in a novel motor control task. Additional healthy pilot subjects (up to 60) will test training protocols and assessments during preparatory design phases of the project.
Interventions
- DEVICE Robotic therapy
- DEVICE Aerobic therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03300258
The ClinicalTrials.gov registry entry for NCT03300258 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Robotic therapy is the first listed.
NCT03300258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03300258 about?
NCT03300258 is a clinical study titled "Robotic Pedaling Therapy for Targeted Neural Plasticity". The aim of this Pilot study is to determine whether robotically targeted lower-limb pedaling therapy can increase the extent of stroke recovery on behavioral measures and induce brain plasticity as measured by functional magnetic resonance imaging (fMRI). Forty (40) adult stroke patients and 80 heal...
What is the current status of trial NCT03300258?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2019-06-01. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT03300258?
The interventions under investigation include: Robotic therapy (DEVICE), Aerobic therapy (DEVICE).
Who is sponsoring clinical trial NCT03300258?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.